Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 17 studies | 60% ± 21% | |
astrocyte | 5 studies | 27% ± 9% | |
glutamatergic neuron | 5 studies | 33% ± 16% | |
GABAergic neuron | 4 studies | 28% ± 11% | |
endothelial cell | 3 studies | 25% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 28% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 38% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 43177.86 | 2637 / 2642 | 100% | 107.46 | 703 / 705 |
thymus | 99% | 12931.85 | 649 / 653 | 99% | 53.43 | 599 / 605 |
prostate | 89% | 6119.84 | 218 / 245 | 99% | 31.78 | 496 / 502 |
stomach | 90% | 6176.48 | 324 / 359 | 94% | 23.31 | 268 / 286 |
kidney | 84% | 5455.53 | 75 / 89 | 96% | 24.80 | 862 / 901 |
intestine | 86% | 5206.49 | 827 / 966 | 94% | 24.53 | 493 / 527 |
breast | 74% | 4324.48 | 341 / 459 | 93% | 24.13 | 1036 / 1118 |
skin | 67% | 3385.60 | 1212 / 1809 | 92% | 26.09 | 432 / 472 |
adrenal gland | 68% | 3554.03 | 176 / 258 | 90% | 52.90 | 207 / 230 |
lung | 75% | 4130.62 | 435 / 578 | 82% | 15.44 | 949 / 1155 |
bladder | 71% | 3419.52 | 15 / 21 | 72% | 13.39 | 361 / 504 |
liver | 59% | 3139.89 | 133 / 226 | 83% | 18.40 | 339 / 406 |
esophagus | 51% | 2977.20 | 732 / 1445 | 84% | 21.73 | 153 / 183 |
pancreas | 31% | 1542.33 | 103 / 328 | 96% | 22.71 | 170 / 178 |
uterus | 39% | 1951.57 | 66 / 170 | 77% | 14.47 | 354 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.77 | 1 / 1 |
spleen | 100% | 8928.18 | 240 / 241 | 0% | 0 | 0 / 0 |
ovary | 15% | 669.87 | 27 / 180 | 82% | 19.40 | 353 / 430 |
eye | 0% | 0 | 0 / 0 | 91% | 16.37 | 73 / 80 |
tonsil | 0% | 0 | 0 / 0 | 87% | 18.73 | 39 / 45 |
adipose | 73% | 4216.18 | 882 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 73% | 4387.82 | 976 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 71% | 7142.36 | 657 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 9.23 | 19 / 29 |
heart | 61% | 3165.80 | 522 / 861 | 0% | 0 | 0 / 0 |
muscle | 15% | 657.01 | 122 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060049 | Biological process | regulation of protein glycosylation |
GO_0032384 | Biological process | negative regulation of intracellular cholesterol transport |
GO_0070723 | Biological process | response to cholesterol |
GO_0006687 | Biological process | glycosphingolipid metabolic process |
GO_0090370 | Biological process | negative regulation of cholesterol efflux |
GO_0019218 | Biological process | regulation of steroid metabolic process |
GO_0001573 | Biological process | ganglioside metabolic process |
GO_0006684 | Biological process | sphingomyelin metabolic process |
GO_0055085 | Biological process | transmembrane transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_1904375 | Biological process | regulation of protein localization to cell periphery |
GO_2000008 | Biological process | regulation of protein localization to cell surface |
GO_0032289 | Biological process | central nervous system myelin formation |
GO_1905598 | Biological process | negative regulation of low-density lipoprotein receptor activity |
GO_0006869 | Biological process | lipid transport |
GO_0045939 | Biological process | negative regulation of steroid metabolic process |
GO_0090156 | Biological process | intracellular sphingolipid homeostasis |
GO_1902004 | Biological process | positive regulation of amyloid-beta formation |
GO_1902993 | Biological process | positive regulation of amyloid precursor protein catabolic process |
GO_0046512 | Biological process | sphingosine biosynthetic process |
GO_1901873 | Biological process | regulation of post-translational protein modification |
GO_0032805 | Biological process | positive regulation of low-density lipoprotein particle receptor catabolic process |
GO_0045540 | Biological process | regulation of cholesterol biosynthetic process |
GO_0048545 | Biological process | response to steroid hormone |
GO_0042986 | Biological process | positive regulation of amyloid precursor protein biosynthetic process |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0006629 | Biological process | lipid metabolic process |
GO_1905601 | Biological process | negative regulation of receptor-mediated endocytosis involved in cholesterol transport |
GO_0007626 | Biological process | locomotory behavior |
GO_0032383 | Biological process | regulation of intracellular cholesterol transport |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0043190 | Cellular component | ATP-binding cassette (ABC) transporter complex |
GO_0005815 | Cellular component | microtubule organizing center |
GO_0005764 | Cellular component | lysosome |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0010008 | Cellular component | endosome membrane |
GO_0005768 | Cellular component | endosome |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0140359 | Molecular function | ABC-type transporter activity |
GO_0099038 | Molecular function | ceramide floppase activity |
GO_0000166 | Molecular function | nucleotide binding |
GO_0061135 | Molecular function | endopeptidase regulator activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005319 | Molecular function | lipid transporter activity |
GO_0042626 | Molecular function | ATPase-coupled transmembrane transporter activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | ABCA2 |
Protein name | ATP binding cassette subfamily A member 2 ATP-binding cassette sub-family A member 2 (EC 7.6.2.-) (ATP-binding cassette transporter 2) (ATP-binding cassette 2) ABCA2 protein ATP-binding cassette protein ATP-binding cassette sub-family A member 2 |
Synonyms | ABC2 KIAA1062 |
Description | FUNCTION: Probable lipid transporter that modulates cholesterol sequestration in the late endosome/lysosome by regulating the intracellular sphingolipid metabolism, in turn participates in cholesterol homeostasis (Probable). May alter the transbilayer distribution of ceramide in the intraluminal membrane lipid bilayer, favoring its retention in the outer leaflet that results in increased acid ceramidase activity in the late endosome/lysosome, facilitating ceramide deacylation to sphingosine leading to the sequestration of free cholesterol in lysosomes . In addition regulates amyloid-beta production either by activating a signaling pathway that regulates amyloid precursor protein transcription through the modulation of sphingolipid metabolism or through its role in gamma-secretase processing of APP . May play a role in myelin formation (By similarity). . |
Accessions | ENST00000371605.7 [Q9BZC7-1] H7C5M6 ENST00000490486.2 H0Y8C9 Q08EJ9 ENST00000614293 ENST00000341511.11 [Q9BZC7-3] H0Y8E3 Q9BZC7 Q13039 Q96HC2 ENST00000488535.2 ENST00000479446.5 Q6P2G5 ENST00000614293.5 [Q9BZC7-4] H0Y8D6 A0A087WXK5 ENST00000470535.2 ENST00000487109.5 E9PGB2 |